Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:32 pm Sale | 13G | Autolus Therapeutics plc AUTL | Paradigm Biocapital Advisors LP | 0 0.000% | -12,611,335 (Position Closed) | View |
| 2024-11-14 1:44 pm Sale | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 30,734,957 11.600% | -2,792,205 (-8.33%) | View |
| 2024-11-14 09:12 am Purchase | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital LP | 15,272,172 5.740% | 3,402,875 (+28.67%) | View |
| 2024-11-12 09:50 am Purchase | 13G | Autolus Therapeutics plc AUTL | FMR LLC | 17,773,873 6.679% | 17,773,873 (New Position) | View |
| 2024-11-08 10:52 am Purchase | 13G | Autolus Therapeutics plc AUTL | WELLINGTON MANAGEMENT GROUP LLP | 24,220,226 9.110% | 24,220,226 (New Position) | View |
| 2024-10-25 4:01 pm Purchase | 13D | Autolus Therapeutics plc AUTL | PPF Group N.V. | 14,782,275 5.600% | 14,782,275 (New Position) | View |
| 2024-05-21 4:30 pm Unchanged | 13D | Autolus Therapeutics plc AUTL | Blackstone Inc. BX | 23,750,917 8.800% | 0 (Unchanged) | View |
| 2024-03-25 4:10 pm Purchase | 13D | Autolus Therapeutics plc AUTL | Kellnerova Renata | 14,612,275 5.500% | 14,612,275 (New Position) | View |
| 2024-02-21 5:01 pm Purchase | 13D | Autolus Therapeutics plc AUTL | BioNTech SE BNTX | 33,333,333 12.500% | 33,333,333 (New Position) | View |
| 2024-02-14 4:08 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Paradigm Biocapital Advisors LP | 12,611,335 7.200% | 2,512,751 (+24.88%) | View |
| 2024-02-14 2:41 pm Sale | 13G | Autolus Therapeutics plc AUTL | ARMISTICE CAPITAL LLC | 3,850,000 2.210% | -6,374,000 (-62.34%) | View |
| 2024-02-14 08:37 am Sale | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital LP | 11,869,297 6.820% | -3,130,703 (-20.87%) | View |
| 2024-02-13 6:41 pm Unchanged | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 14.400% | 0 (Unchanged) | View |
| 2024-01-31 4:10 pm Sale | 13G | Autolus Therapeutics plc AUTL | Tetragon Financial Management LP | 8,000,000 4.600% | -1,461,883 (-15.45%) | View |
| 2023-07-10 5:00 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Paradigm Biocapital Advisors LP | 10,098,584 5.800% | 10,098,584 (New Position) | View |
| 2023-03-20 09:13 am Purchase | 13G | Autolus Therapeutics plc AUTL | Tetragon Financial Management LP | 9,461,883 5.500% | 9,461,883 (New Position) | View |
| 2023-02-14 5:02 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Nantahala Capital Management LLC | 7,782,018 4.700% | 3,704,509 (+90.85%) | View |
| 2023-02-14 12:09 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Frazier Life Sciences Public Fund L.P. | 3,746,857 2.200% | 16,200 (+0.43%) | View |
| 2023-02-14 12:02 pm Purchase | 13G | Autolus Therapeutics plc AUTL | ARMISTICE CAPITAL LLC | 10,224,000 5.910% | 10,224,000 (New Position) | View |
| 2023-02-14 10:28 am Purchase | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 19.700% | 14,000,000 (+71.70%) | View |